REPLITZA 1/500 MG 30 F.C. TABS

About Repaglinide Meglitinide derivative Insulin Secretagogue Oral anti-diabetic drug. Mechanism of Action of Repaglinide It is a quick and short acting antidiabetic drug which exerts it`s action by stimulating insulin release from ?-cells of pancreas. It acts by binding to sulfonylurea receptor and to other distinct receptors and closes ATP dependent potassium channels and thus causes depolarization. This depolarization of pancreatic ? cells causes opening of Ca channels and increased Ca influx which induces insulin secretion. Indications for Repaglinide Non-insulin dependent diabetes mellitus (as adjunct to diet and exercise) Interactions for Repaglinide Ketoconazole miconazole and erythromycin: Metabolism of repaglinide inhibited. Troglitazone rifampicin barbiturates and carbamazepine: Increase metabolism of repaglinide.